Quantitative Biology > Molecular Networks
[Submitted on 27 Jan 2020 (this version), latest version 27 Oct 2020 (v2)]
Title:Underlying mechanisms of two catalase-dependent apoptotic pathways in plasma-treated cancer cells
View PDFAbstract:Cancer treatment by cold atmospheric plasma (CAP) offers the possibility to selectively eliminate cancer cells while leaving surrounding, normal cells, unaffected. The mechanisms underlying the CAP selectivity towards cancer cells are yet not fully understood, but it has been proposed that two apoptosis-inducing signaling pathways in the extracellular compartment are reactivated when catalase in the cell membrane of cancer cells is inactivated. Since CAP has the capacity to inactivate catalase, CAP may thus be used to induce cancer cell death by reactivation of these signaling pathways. A better insight of this specific apoptosis-inducing mechanism - especially the role of catalase inactivation - could be useful to increase our understanding of possible roles of CAP constituents in cancer treatment. In the present study, a mathematical model describing the reaction kinetics of the two apoptosis-inducing signaling pathways is developed and used to theoretically investigate their catalase-dependent reactivation. The results show that when only the reaction kinetics is considered, just one of the pathways may be responsible for apoptosis induction. This pathway requires a high catalase concentration (in the order of mM) to be inhibited, which thus can be assumed to be the condition of cancer cells before CAP treatment, and it can only be reactivated by inactivation of about 99% of the catalase. This model is a first step into the efforts that should be taken to quantitatively understand the complex mechanisms of the role of CAP and catalase in the apoptosis-inducing signaling pathways, but will need to be further extended before it can capture the entire mechanism. Still, it gives some important insights regarding necessary conditions in order for the proposed mechanism to represent a feasible explanation of selective CAP treatment of cancer cells.
Submission history
From: Charlotta Bengtson [view email][v1] Mon, 27 Jan 2020 17:55:38 UTC (882 KB)
[v2] Tue, 27 Oct 2020 15:49:13 UTC (760 KB)
References & Citations
Bibliographic and Citation Tools
Bibliographic Explorer (What is the Explorer?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)
Code, Data and Media Associated with this Article
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)
Demos
Recommenders and Search Tools
Influence Flower (What are Influence Flowers?)
Connected Papers (What is Connected Papers?)
CORE Recommender (What is CORE?)
arXivLabs: experimental projects with community collaborators
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.